{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:56:33Z","timestamp":1768341393598,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The complicated replication mechanisms of hepatitis B virus (HBV) have impeded HBV studies and anti-HBV therapy development as well. Herein we report efficient genome replication of HBV applying adenovirus vectors (AdVs) showing high transduction efficiency. Even in primary hepatocytes derived from humanized mice the transduction efficiencies using AdVs were 450-fold higher compared than those using plasmids. By using an expression unit consisting of the CMV promoter, 1.03-copy HBV genome and foreign poly(A) signal, we successfully generated an improved AdV (HBV103-AdV) that efficiently provided 58 times more pregenomic RNA than previously reported AdVs. The HBV103-AdV-mediated HBV replication was easily and precisely detected using quantitative real-time PCR in primary hepatocytes as well as in HepG2 cells. Notably, when the AdV containing replication-defective HBV genome of 1.14 copy was transduced, we observed that HBV DNA-containing circular molecules (pseudo-ccc DNA) were produced, which were probably generated through homologous recombination. However, the replication-defective HBV103-AdV hardly yielded the pseudo-ccc, probably because the repeated sequences are vey short. Additionally, the efficacies of entecavir and lamivudine were quantitatively evaluated using this system at only 4 days postinfection with HBV103-AdVs. Therefore, this system offers high production of HBV genome replication and thus could become used widely.<\/jats:p>","DOI":"10.1038\/srep41851","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T14:23:22Z","timestamp":1486131802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficient genome replication of hepatitis B virus using adenovirus vector: a compact pregenomic RNA-expression unit"],"prefix":"10.1038","volume":"7","author":[{"given":"Mariko","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norie","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Kanegae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"BFsrep41851_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"M Naghavi","year":"2015","unstructured":"Naghavi, M. et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117\u2013171 (2015).","journal-title":"Lancet"},{"key":"BFsrep41851_CR2","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem, D. & Prince, A. M. Hepatitis B Virus Infection - Natural History and Clinical Consequences. N Engl J Med 350, 1118\u20131129 (2004).","journal-title":"N Engl J Med"},{"key":"BFsrep41851_CR3","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/0016-5085(88)90367-8","volume":"95","author":"JH Hoofnagle","year":"1988","unstructured":"Hoofnagle, J. H. et al. Randomized, controlled trial of recombinant human \u03b1-interferon in patients with chronic hepatitis B. Gastroenterology 95, 1318\u20131325 (1988).","journal-title":"Gastroenterology"},{"key":"BFsrep41851_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0140-6736(87)92735-8","volume":"330","author":"GJM Alexander","year":"1986","unstructured":"Alexander, G. J. M. et al. Loss of HBsAg with Interferon Therapy in Chronic Hepatitis B Virus Infection. Lancet 330, 66\u201369 (1986).","journal-title":"Lancet"},{"key":"BFsrep41851_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-2005-915647","volume":"25","author":"RP Perrillo","year":"2005","unstructured":"Perrillo, R. P. Current Treatment of Chronic Hepatitis B : Benefits and Limitations. Semin Liver Dis. 25, 20\u201328 (2005).","journal-title":"Semin Liver Dis"},{"key":"BFsrep41851_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","volume":"479\u2013480","author":"C Seeger","year":"2015","unstructured":"Seeger, C. & Mason, W. S. Molecular biology of hepatitis B virus infection. Virology 479\u2013480, 672\u2013686 (2015).","journal-title":"Virology"},{"key":"BFsrep41851_CR7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.ajpath.2015.01.028","volume":"185","author":"Y Ishida","year":"2015","unstructured":"Ishida, Y. et al. Novel Robust in Vitro Hepatitis B Virus Infection Model Using Fresh Human Hepatocytes Isolated from Humanized Mice. Am. J. Pathol. 185, 1275\u20131285 (2015).","journal-title":"Am. J. Pathol."},{"key":"BFsrep41851_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2133\/dmpk.DMPK-10-RG-047","volume":"25","author":"C Yamasaki","year":"2010","unstructured":"Yamasaki, C. et al. In vitro evaluation of cytochrome P450 and glucuronidation activities in hepatocytes isolated from liver-humanized mice. Drug Metab. Pharmacokinet. 25, 539\u2013550 (2010).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"BFsrep41851_CR9","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jhep.2006.05.019","volume":"45","author":"D Sun","year":"2006","unstructured":"Sun, D. & Nassal, M. Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. J. Hepatol. 45, 636\u2013645 (2006).","journal-title":"J. Hepatol."},{"key":"BFsrep41851_CR10","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","volume":"41","author":"SK Ladner","year":"1997","unstructured":"Ladner, S. K. et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 41, 1715\u201320 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFsrep41851_CR11","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1128\/jvi.62.8.2836-2844.1988","volume":"62","author":"MA Sells","year":"1988","unstructured":"Sells, M. A., Zelent, A. Z., Shvartsman, M. & Acs, G. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J. Virol. 62, 2836\u20132844 (1988).","journal-title":"J. Virol."},{"key":"BFsrep41851_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","volume":"84","author":"MA Sells","year":"1987","unstructured":"Sells, M. A., Chen, M. L. & Acs, G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84, 1005\u20131009 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep41851_CR13","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","volume":"443","author":"M Iwamoto","year":"2014","unstructured":"Iwamoto, M. et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochem. Biophys. Res. Commun. 443, 808\u2013813 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFsrep41851_CR14","first-page":"1","volume":"2012","author":"H Yan","year":"2012","unstructured":"Yan, H. et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012, 1\u201328 (2012).","journal-title":"Elife"},{"key":"BFsrep41851_CR15","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1128\/JVI.75.11.5108-5118.2001","volume":"75","author":"MF Sprinzl","year":"2001","unstructured":"Sprinzl, M. F., Oberwinkler, H., Schaller, H. & Protzer, U. Transfer of Hepatitis B Virus Genome by Adenovirus Vectors into Cultured Cells and Mice : Crossing the Species Barrier. J. Virol. 75, 5108\u20135118 (2001).","journal-title":"J. Virol."},{"key":"BFsrep41851_CR16","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1128\/JVI.75.3.1104-1116.2001","volume":"75","author":"S Ren","year":"2001","unstructured":"Ren, S. & Nassal, M. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors. J. Virol. 75, 1104\u20131116 (2001).","journal-title":"J. Virol."},{"key":"BFsrep41851_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0092-8674(85)80025-8","volume":"41","author":"M Boshart","year":"1985","unstructured":"Boshart, M. et al. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521\u2013530 (1985).","journal-title":"Cell"},{"key":"BFsrep41851_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","volume":"108","author":"H Niwa","year":"1991","unstructured":"Niwa, H., Yamamura, K. & Miyazaki, J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193\u20139 (1991).","journal-title":"Gene"},{"key":"BFsrep41851_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0378-1119(01)00350-X","volume":"265","author":"J Guhaniyogi","year":"2001","unstructured":"Guhaniyogi, J. & Brewer, G. Regulation of mRNA stability in mammalian cells. Gene 265, 11\u201323 (2001).","journal-title":"Gene"},{"key":"BFsrep41851_CR20","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1128\/MCB.7.10.3663","volume":"7","author":"M Affolter","year":"1987","unstructured":"Affolter, M., C\u00f4t\u00e9, J., Renaud, J. & Ruiz-Carrillo, A. Regulation of histone and beta A-globin gene expression during differentiation of chicken erythroid cells. Mol. Cell. Biol. 7, 3663\u201372 (1987).","journal-title":"Mol. Cell. Biol."},{"key":"BFsrep41851_CR21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/jvi.64.2.613-620.1990","volume":"64","author":"G Radziwill","year":"1990","unstructured":"Radziwill, G., Tucker, W. & Schaller, H. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J. Virol. 64, 613\u2013620 (1990).","journal-title":"J. Virol."},{"key":"BFsrep41851_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"J Zhang","year":"1999","unstructured":"Zhang, J., Chung, T. & Oldenburg, K. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen. 4, 67\u201373 (1999).","journal-title":"J. Biomol. Screen."},{"key":"BFsrep41851_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1128\/AAC.46.1.82-88.2002","volume":"46","author":"PL Marion","year":"2002","unstructured":"Marion, P. L., Salazar, F. H., Winters, M. A. & Colonno, R. J. Potent Efficacy of Entecavir (BMS-200475) in a Duck Model of Hepatitis B Virus Replication. Antimicrob. Agents Chemother. 46, 82\u201388 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFsrep41851_CR24","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1128\/AAC.42.12.3179","volume":"42","author":"RW King","year":"1998","unstructured":"King, R. W. et al. Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine. Antimicrob. Agents Chemother. 42, 3179\u20133186 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFsrep41851_CR25","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1128\/JVI.02395-06","volume":"81","author":"DR Langley","year":"2007","unstructured":"Langley, D. R. et al. Inhibition of hepatitis B virus polymerase by entecavir. J. Virol. 81, 3992\u20134001 (2007).","journal-title":"J. Virol."},{"key":"BFsrep41851_CR26","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1128\/JVI.02756-13","volume":"88","author":"Z Wang","year":"2014","unstructured":"Wang, Z. et al. Adenoviral Delivery of Recombinant Hepatitis B Virus Expressing Foreign Antigenic Epitopes for Immunotherapy of Persistent Viral Infection. J. Virol. 88, 3004\u20133015 (2014).","journal-title":"J. Virol."},{"key":"BFsrep41851_CR27","doi-asserted-by":"publisher","first-page":"e53392","DOI":"10.1371\/journal.pone.0053392","volume":"8","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. Truncated Active Human Matrix Metalloproteinase-8 Delivered by a Chimeric Adenovirus-Hepatitis B Virus Vector Ameliorates Rat Liver Cirrhosis. PLoS One 8, e53392 (2013).","journal-title":"PLoS One"},{"key":"BFsrep41851_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1348-0421.2006.tb03829.x","volume":"50","author":"H Fukuda","year":"2006","unstructured":"Fukuda, H., Terashima, M., Koshikawa, M., Kanegae, Y. & Saito, I. Possible mechanism of adenovirus generation from a cloned viral genome tagged with nucleotides at its ends. Microbiol Immunol 50, 643\u2013654 (2006).","journal-title":"Microbiol Immunol"},{"key":"BFsrep41851_CR29","first-page":"1511","volume":"39","author":"YH Huang","year":"2011","unstructured":"Huang, Y. H. et al. A murine model of hepatitis B-associated hepatocellular carcinoma generated by adeno-associated virus-mediated gene delivery. Int. J. Oncol. 39, 1511\u20131519 (2011).","journal-title":"Int. J. Oncol."},{"key":"BFsrep41851_CR30","first-page":"1","volume":"10","author":"L Ye","year":"2015","unstructured":"Ye, L. et al. Adeno-associated virus vector mediated delivery of the HBV genome induces chronic hepatitis B virus infection and liver fibrosis in mice. PLoS One 10, 1\u201316 (2015).","journal-title":"PLoS One"},{"key":"BFsrep41851_CR31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1089\/hum.2007.085","volume":"18","author":"M Nakai","year":"2007","unstructured":"Nakai, M. et al. Expression of pIX gene induced by transgene promoter: possible cause of host immune response in first-generation adenoviral vectors. Hum Gene Ther 18, 925\u2013936 (2007).","journal-title":"Hum Gene Ther"},{"key":"BFsrep41851_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.virusres.2011.05.019","volume":"160","author":"T Chiyo","year":"2011","unstructured":"Chiyo, T. et al. Conditional gene expression in hepatitis C virus transgenic mice without induction of severe liver injury using a non-inflammatory Cre-expressing adenovirus. Virus Res. 160, 89\u201397 (2011).","journal-title":"Virus Res."},{"key":"BFsrep41851_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jmb.2009.04.057","volume":"390","author":"S Kondo","year":"2009","unstructured":"Kondo, S., Takata, Y., Nakano, M., Saito, I. & Kanegae, Y. Activities of Various FLP Recombinases Expressed by Adenovirus Vectors in Mammalian Cells. J. Mol. Biol. 390, 221\u2013230 (2009).","journal-title":"J. Mol. Biol."},{"key":"BFsrep41851_CR34","doi-asserted-by":"publisher","first-page":"11916","DOI":"10.1128\/JVI.05373-11","volume":"85","author":"TB Lentz","year":"2011","unstructured":"Lentz, T. B. & Loeb, D. D. Roles of the Envelope Proteins in the Amplification of Covalently Closed Circular DNA and Completion of Synthesis of the Plus-Strand DNA in Hepatitis B Virus. J. Virol. 85, 11916\u201311927 (2011).","journal-title":"J. Virol."},{"key":"BFsrep41851_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","volume":"36","author":"FL Graham","year":"1977","unstructured":"Graham, F. L., Smiley, J., Russell, W. C. & Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36, 59\u201374 (1977).","journal-title":"J Gen Virol"},{"key":"BFsrep41851_CR36","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/hep.21345","volume":"44","author":"M Sugiyama","year":"2006","unstructured":"Sugiyama, M. et al. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 44, 915\u2013924 (2006).","journal-title":"Hepatology"},{"key":"BFsrep41851_CR37","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/srep01136","volume":"3","author":"A Maekawa","year":"2013","unstructured":"Maekawa, A. et al. Efficient production of adenovirus vector lacking genes of virus-associated RNAs that disturb cellular RNAi machinery. Sci. Rep. 3, 1136 (2013).","journal-title":"Sci. Rep"},{"key":"BFsrep41851_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.7883\/yoken1952.47.157","volume":"47","author":"Y Kanegae","year":"1994","unstructured":"Kanegae, Y., Makimura, M. & Saito, I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 47, 157\u201366 (1994).","journal-title":"Jpn. J. Med. Sci. Biol."},{"key":"BFsrep41851_CR39","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbrc.2011.12.016","volume":"417","author":"Z Pei","year":"2012","unstructured":"Pei, Z., Kondo, S., Kanegae, Y. & Saito, I. Copy number of adenoviral vector genome transduced into target cells can be measured using quantitative PCR: Application to vector titration. Biochem. Biophys. Res. Commun. 417, 945\u2013950 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFsrep41851_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gt.2014.124","volume":"22","author":"M Suzuki","year":"2015","unstructured":"Suzuki, M. et al. Preferable sites and orientations of transgene inserted in the adenovirus vector genome: The E3 site may be unfavorable for transgene position. Gene Ther. 22, 421\u2013429 (2015).","journal-title":"Gene Ther"},{"key":"BFsrep41851_CR41","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1093\/nar\/gkq966","volume":"39","author":"Y Kanegae","year":"2011","unstructured":"Kanegae, Y. et al. High-level expression by tissue\/cancer-specific promoter with strict specificity using a single-adenoviral vector. Nucleic Acids Res 39, e7 (2011).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep41851_CR42","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1128\/jvi.54.3.711-719.1985","volume":"54","author":"I Saito","year":"1985","unstructured":"Saito, I., Oya, Y., Yamamoto, K., Yuasa, T. & Shimojo, H. Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J Virol 54, 711\u2013719 (1985).","journal-title":"J Virol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep41851.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep41851","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep41851.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T01:52:55Z","timestamp":1671846775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep41851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,8]]}},"alternative-id":["BFsrep41851"],"URL":"https:\/\/doi.org\/10.1038\/srep41851","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]},"assertion":[{"value":"3 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41851"}}